Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New blood test for deadly snake disease
Boa constrictor
IBD affects snakes in captivity, as well as those sold as pets.
Scientists introduce a screening method for IBD

A simple blood test has been developed to screen for inclusion body disease (IBD), a debilitating and usually fatal disease most commonly found in boa constrictors.

Scientists from the University of Florida's College of Veterinary Medicine developed the test by studying a unique protein that accumulates in the cells of snakes with IBD.

While the cause of the disease remains unclear, the team found links between the protein and a family of viruses that predominantly infect rodents, but may also affect humans. According to researchers, however, there is no evidence to suggest people can become infected with the virus causing IBD.

The disease is highly infectious and is first said to have been seen in snakes in the late 1970s. The disease affects both animals in captivity and those sold as pets throughout the world. Pythons and other snake species from the boid family can also occasionally become infected disease-causing virus.

Co-author Elliott Jacobson, professor of zoological medicine at the university, said: "We don’t know the prevalence, but we see more of IBD in the United States because there are some 2 million boas being kept as pets in this country."

Snakes infected with the disease may shows neurological signs such as head-tilting, chronic regurgitation or disequilibrium. However, a population of snakes are subclinical, appearing healthy despite being infected with IBD.

Dr Jacobson explained: "That’s a big problem, because healthy-seeming animals that are affected with IBD are being sold and sent around the world. However, they may develop the disease sometime later and may be the source of infection for other snakes."

The new test is now being offered at the university's veterinary diagnostic laboratories. It is intended to be used alongside existing molecular and histological tests, which are more readily available, but also more expensive.

Researchers say the blood test will provide veterinary surgeons with a first-line diagnostic tool to screen for IBD in animals displaying signs of the disease, or even before signs occur.

Golden gate virus was discovered by researchers from the University of California-San Francisco in 2012, and scientists now believe it could be a cause of IBD. However, Dr Jacobson says further research is needed to confirm this.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.